NASDAQ · Biotechnology
Viking Therapeutics Inc (VKTX)
$24.77
-4.14%
44
In band
Moving averages
SMA 200$32.20-23.07%
Company profile
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.
SectorHealthcare
IndustryBiotechnology
Market cap$3.63B
P/E ratioNone
EPS$-5.42
Beta0.753
Dividend yield0.00%
52-week high$43.10
52-week low$23.82
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
TARS
Tarsus Pharmaceuticals Inc
RSI 54
ATAI
ATAI Life Sciences N.V.
RSI 62
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 34
AUPH
Aurinia Pharmaceuticals Inc
RSI 32
MRVI
Maravai LifeSciences Holdings Inc - Class A
RSI 48
IBRX
ImmunityBio Inc
RSI 40
RSI alerts for VKTX
An email when VKTX closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 2:26 AM EST